- Home
- News & Events
- Conferences & Events in the Philippines
- Siemens Healthineers at the PAMET 25th Mid Year Convention
Siemens Healthineers at the PAMET 25th Midyear ConventionMay 19 – 21, 2021 | PAMET Mid Year Convention
Siemens Healthineers | PAMET 25TH Midyear Convention | May 19-21, 2021
About
The Philippine Association of Medical Technologists, Inc. (PAMET) holds its 25th Midyear Convention with the theme "PAMET Into the Future: Silver Lining, Golden Opportunities."
Siemens Healthineers showcases its latest innovation in the field of laboratory diagnostics and point-of-care for urinalysis such as Atellica® 1500, a digital automated urinalysis system. Furthermore, discover more about our comprehensive COVID-19 Testing portfolio and its position in the setting of vaccination - highlighting SARS-CoV-2 Serology Testing as we move into the next phase of the pandemic.
At Siemens Healthineers, we continue to support healthcare providers and enabling healthcare systems to provide the best possible care for patients.
Date: 19 to 21 May 2021
Venue: PAMET Mid-year Virtual Showroom
"How can Covid-19 serology testing support vaccine rollout?"
As we start rolling out COVID-19 vaccination programs, we invite you to join our clinical presentation on "How can Covid-19 serology testing support vaccine rollout?" at the PAMET 25th Midyear Convention.
Speaker: Dr. Jecyll S. Dayanghirang, Marketing Manager for Diagnostics Siemens Healthineers Philippines
When: May 20, 2021 | 5:15 PM Philippine Standard Time
Highlights
Atellica® 1500 Automated Urinalysis System
A urinalysis system so advanced, it lets you do less and see more. Combining the CLINITEK Novus® Analyzer and the new Atellica® UAS 800 Analyzer* into one completely automated unit, the Atellica 1500 Automated Urinalysis System* sets the new standard for accuracy and efficiency. It is a truly digital automated urinalysis system, and lets you manage more samples with less staff in shorter time, while never compromising on high-quality results.
The system
The Analyzers
CLINITEK Novus® Automated Urine Chemistry Analyzer
The Analyzers
Atellica® UAS 800 Urine Sediment Analyzer
Do Less and See More
Atellica® 1500 Automated Urinalysis System
The Atellica® 1500 Automated Urinalysis System* lets you manage more samples with less staff in a shorter time, while never compromising on high-quality results.
- Measurement technology: Digital microscopy imaging with a dual-focusing mechanism to generate clear images
- Combines dry-pad urine chemistry and powerful digital microscopy into a single, streamlined unit
- Throughput range: Up to 240 samples per hour
- Streamlines the detection of UTIs and early kidney disease for better clinical outcome
Critical Care & COVID-19
COVID-19 response ꟷ Clinical
We are committed to support front-line healthcare professionals and help them to deliver high-value critical care to patients at each stage of COVID-19 disease management: diagnosis, prognosis, therapy and follow-up.
Learn more about our COVID-19 comprehensive test solutions:
Instruments for testing and in support of COVID-19
Point of Care Testing
Plays an especially important role in the care of patients affected by the COVID-19 pandemic. The RAPIDPoint® 500e Blood Gas System and epoc® Blood Analysis System are important analyzers supporting COVID-19 response efforts, where blood gas testing plays a critical role in managing infected patients and monitoring their respiratory distress. The analyzers integrate seamlessly into hospital networks with the Point of Care Ecosystem™, which offers remote management of operators and devices.
Laboratory Diagnostics
Fast, accurate detection and monitoring for the health issues that may arise as part of COVID-19 disease management are critical. Our portfolio of systems and assay menu in immunoassay, chemistry, hematology, hemostasis, molecular, and urinalysis, as well as automation, informatics and services can help support the essential role of laboratory diagnostics. We are expanding our infectious disease testing capabilities to address the COVID-19 pandemic.
Point of Care Testing
Plays an especially important role in the care of patients affected by the COVID-19 pandemic. The RAPIDPoint® 500e Blood Gas System and epoc® Blood Analysis System are important analyzers supporting COVID-19 response efforts, where blood gas testing plays a critical role in managing infected patients and monitoring their respiratory distress. The analyzers integrate seamlessly into hospital networks with the Point of Care Ecosystem™, which offers remote management of operators and devices.
Laboratory Diagnostics
Fast, accurate detection and monitoring for the health issues that may arise as part of COVID-19 disease management are critical. Our portfolio of systems and assay menu in immunoassay, chemistry, hematology, hemostasis, molecular, and urinalysis, as well as automation, informatics and services can help support the essential role of laboratory diagnostics. We are expanding our infectious disease testing capabilities to address the COVID-19 pandemic.
Point of Care Testing
Plays an especially important role in the care of patients affected by the COVID-19 pandemic. The RAPIDPoint® 500e Blood Gas System and epoc® Blood Analysis System are important analyzers supporting COVID-19 response efforts, where blood gas testing plays a critical role in managing infected patients and monitoring their respiratory distress. The analyzers integrate seamlessly into hospital networks with the Point of Care Ecosystem™, which offers remote management of operators and devices.
SARS-CoV-2 Serology Testing in the Setting of Vaccination
Serology testing & Vaccines
Vaccine Efficacy
Now that the vaccines are programs are well underway, how do you know if constituency is developing an immune response to vaccines? Vaccines have proven to be effective, but there are still looming questions about what happens next. Learn more about using serology testing as a tool to monitor your community
Vaccine Durability
Confirming an initial immune response shortly after vaccination and tracking antibody levels is essential to the success of any vaccination program. Checking antibody status at 3.6.9 and 12 months after vaccination can provide valuable data. Will individuals require a booster shot? Does immunocompetency or age impact the likelihood of a robust immune response? Learn more about building a robust post vaccination testing programs.
Vaccine Supply Optimization
How can you accelerate vaccination programs in your community? Understanding antibody status plays a key role in promoting public health. Measuring and tracking antibody levels can enable an effective vaccination strategy to help confirm efficacy and promote public health.